A note from our Chair 

2021-22 has been pivotal for the AHSNs and the AHSN Network. While we are still supporting our health and care systems with the recovery from the pandemic, we have undertaken work to set out our vision and strategy and refine our processes to ensure we can meet our collective ambition to transform as many lives as possible through more rapid uptake of high value innovation in health and care.

This report reflects our national AHSN Network priorities and our impacts within these areas of work.

I’d like to thank all my colleagues from across the Network and our partners for their continued support this year. We know that team working is key to health system transformation and our achievements are only possible together.

Professor Gary Ford CBE, FMedSci
Chair of the AHSN Network and Chief Executive of Oxford AHSN

Image: cover of the AHSN Network impact report 21-22

 

 

 

 

 

 

Read the Impact Report PDF. You can see more impact stories on the pages below.

2021/22 impacts

Illustration. Text reads: More than 480,000 patients benefited from our national programmes and initiatives. 1,273 innovations in our national pipeline of innovation. £455 investment leveraged by companies supported by AHSNs.

For more information about specific areas of our work and the impacts, you can navigate through the areas below:

Coloured block with text. Text reads: National innovation spread programmes Coloured block with text. Text reads: Improving safety Coloured block with text. Text reads: Accelerating patient access to NICE-approved technologies and treatments

Coloured block with text. Text reads: Supporting innovators and driving economic growth Coloured block with text. Text reads: Working in partnership Coloured block with text. Text reads: Cross-cutting priorities of our work

Looking back on 2021-22
Blog
AHSN Network releases national impacts
News Feed
AHSN Network supported companies generate £455 million of UK investment
News Feed